• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS CREATININE PLUS VER.2; ENZYMATIC METHOD, CREATININE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS CREATININE PLUS VER.2; ENZYMATIC METHOD, CREATININE Back to Search Results
Catalog Number 03263991190
Medical Device Problem Code High Test Results (2457)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/11/2025
Type of Reportable Event Malfunction
Event or Problem Description
We received an allegation about discrepant results for 1 patient sample tested with creatinine plus ver.2 (crep2) assay on a cobas 6000 c501 module.Initial result: 425.4 ¿mol/l.The customer questioned the initial result and repeated the sample.Repeat result: 74.3 ¿mol/l.The repeat result of 74.3 ¿mol/l was deemed to be correct.Reportedly, an amended report with the correct result was issued.
 
Additional Manufacturer Narrative
The c501 module serial number was (b)(6).The qc was acceptable.The investigation is ongoing.
 
Additional Manufacturer Narrative
Following the installation of the special wash, the customer conducted carry-over experiments as outlined in the troubleshooting guide.The results showed no visible carry-over, indicating successful resolution.The instrument was performing within specifications.The investigation did not identify a product problem.The cause of the event was consistent with a user error where the customer did not follow the instructions for special wash installation as recommended in the product labeling (integrated special wash requirement).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CREATININE PLUS VER.2
Common Device Name
ENZYMATIC METHOD, CREATININE
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhofer strasse 116
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
natalie catton
9115 hague road
indianapolis, IN 46250
MDR Report Key22131213
Report Number1823260-2025-01702
Device Sequence Number8371516
Product Code JFY
UDI-Device Identifier04015630919215
UDI-Public04015630919215
Combination Product (Y/N)N
Initial Reporter CountryNL
PMA/510(K) Number
K024098
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 06/24/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date11/30/2025
Device Catalogue Number03263991190
Device Lot Number85802001
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 05/12/2025
Supplement Date Received by Manufacturer06/04/2025
Initial Report FDA Received Date06/03/2025
Supplement Report FDA Received Date06/24/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Patient SexUnknown
-
-